BDX · 8-K · 20260806PR053790
Products and Technology
BECTON DICKINSON & CO · 2026-08-06 · Importance 31 · Surprise 42 · In source text
BD launched the Elyra™ Thulium Fiber Laser System, expanding its kidney stone care portfolio for urology teams. The company also highlighted the BD® CentroVena One™ Insertion System, designed to simplify central line insertion and enhance patient and clinician safety. In BioPharma Systems, BD’s Vystra™ Injection Pen platform will support a semaglutide launch for self-injection by patients with obesity and type 2 diabetes.
Key facts
- BD was awarded a Vizient Innovative Technology contract for the BD® CentroVena One™ Insertion System. source
- BD launched the Elyra™ Thulium Fiber Laser System to expand its kidney stone care portfolio. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | committed | — | BD was awarded a Vizient Innovative Technology contract for the BD® CentroVena One™ Insertion System. |
| revenue | positive | probable | — | BD launched the Elyra™ Thulium Fiber Laser System to expand its kidney stone care portfolio. |